LS-P-Poppy

LS-P-Poppy: First-in-class antibody-drug conjugate (ADC) targeting fibronectin (PYX-201) for solid tumors

Status:

Open

Trial Type:

Breast Cancer, Early Phase Trials for Multiple Cancer Types, Head and Neck Cancer, Kidney and Bladder Cancer, Lung Cancer, Ovarian Cancer, Pancreas Cancer, Soft Tissue and Bone Cancer

Contact:

Benedito Carneiro, MD

Benedito.carneiro@brownhealth.org